Pharmacovigilance & Drug Safety Software Market Research Report by Product, by Clinical Trial, by Method, by Distribution, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19 – Yahoo Finance

Pharmacovigilance & Drug Safety Software Market Research Report by Product (Adverse Event Reporting Software, Drug Safety Audits Software, and Fully Integrated Software), by Clinical Trial (Phase I, Phase II, and Phase III), by Method, by Distribution, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19
New York, Jan. 10, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Pharmacovigilance & Drug Safety Software Market Research Report by Product, by Clinical Trial, by Method, by Distribution, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19" – https://www.reportlinker.com/p06204775/?utm_source=GNW

The Global Pharmacovigilance & Drug Safety Software Market size was estimated at USD 213.72 million in 2020 and expected to reach USD 231.64 million in 2021, at a CAGR 8.75% to reach USD 384.49 million by 2027.

Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Pharmacovigilance & Drug Safety Software to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software, and Issue Tracking Software.

Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.

Based on Method, the market was studied across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.

Based on Distribution, the market was studied across On-Cloud and On-Premise.

Based on End User, the market was studied across Business Process Outsourcing Firms, Contract Research Organizations, Pharma & Biotech Companies, and Pharmacovigilance Service Providers.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmacovigilance & Drug Safety Software Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmacovigilance & Drug Safety Software Market, including 4C PHARMA SOLUTIONS, AB Cube, Accenture, Advera Health Analytics, Inc., ArisGlobal, Clinevo Technologies, Cognizant, Ennov, Extedo GMBH, Indegene, IQVIA Inc., Online Business Applications, Oracle Corporation, Sarjen Systems Pvt, Sparta Systems, UMBRA Global LLC, United BioSource Corporation, VigiFlow, and Wipro.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Pharmacovigilance & Drug Safety Software Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmacovigilance & Drug Safety Software Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmacovigilance & Drug Safety Software Market?
4. What is the competitive strategic window for opportunities in the Global Pharmacovigilance & Drug Safety Software Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmacovigilance & Drug Safety Software Market?
6. What is the market share of the leading vendors in the Global Pharmacovigilance & Drug Safety Software Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmacovigilance & Drug Safety Software Market?
Read the full report: https://www.reportlinker.com/p06204775/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

BioMarin CEO JJ Bienaimé joins Yahoo Finance Live’s Julie Hyman and Anjalee Khemlani to discuss the company's first gene therapy product targeted to patients dealing with hemophilia, the future of biotechnology, biotech stocks, and key takeaways from JPMorgan’s annual health care conference.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Consumer prices rose 7% in December, as compared to the same month in 2020, according to data from the Labor Department released in January. Now, U.S. inflation is at a nearly 40-year-high.
It's Wednesday morning, and Alibaba Group Holding (NYSE: BABA) stock is still going up. Do you remember what I said about Alibaba yesterday? Well, this morning, the chorus singing Alibaba's praises got even bigger.
Cathie Wood, the star fund manager and chief executive of ARK Invest, in a Tuesday monthly market update says that the used car market is where she is expecting possible losses after a surge in values.
Several top U.S. oil stocks are in buy range Wednesday as oil prices rise amid OPEC+ production disruptions.
Shares of Chinese electric-vehicle maker Nio (NYSE: NIO) were trading higher on Wednesday, after the company's communications chief shared some upbeat details around Nio's pricing performance in December. As of noon ET, Nio's American depositary shares were up about 3.3% from Tuesday's closing price. Ma Lin, Nio's corporate communications chief, said in a WeChat post that the average sales price across Nio's 3 current models in December was 443,500 Chinese yuan, or about $69,700.
The company has been giving away too much money
The stock of QuantumScape (NYSE: QS) crashed 23% in December, according to data provided by S&P Global Market Intelligence. QuantumScape stock is already down another 10.9% this month, as of the time of this writing. The passage of President Joe Biden's $1.2 trillion infrastructure bill that earmarked $7.5 billion on building an EV charging network of 500,000 chargers sent EV stocks surging in November.
Shares of Kinder Morgan (NYSE: KMI) have quietly gained 9% year to date as the energy sector continues to outperform the broader market. The largest natural gas pipeline infrastructure company in the U.S. is expected to report its fourth-quarter and full-year 2021 results in about a week. Let's dive into Kinder Morgan's business and its 6.3% dividend yield to see what makes it a top dividend stock for 2022.
Here’s one to be aware of for 2022: Value stocks will most likely beat their growth counterparts. * The Vanguard S&P 500 Growth Index exchange traded fund (VOOG) is down 5.6% year to date, while the Vanguard S&P 500 Value Index fund (VOOV) is flat. * Value groups including banks and energy stocks are crushing growth stocks like Ark Invest’s favorite names.
The U.S.-listed shares of Koninklijke Philips N.V. plunged 15.7% toward a near two-year low in morning trading Wednesday, after the Netherlands-based medical technologies and products company provided a downbeat revenue outlook, citing "intensified global supply chain shortages" and the postponement of customer equipment installations. The stock, which was the biggest decliner listed on the NYSE, was headed for the biggest one-day selloff since it dropped 15.9% on Oct. 15, 2008. The stock is als
The Canadian e-commerce giant has potential to boost revenue by about 30% over the next several years, William Blair analysts say
For example, Novavax (NASDAQ: NVAX) soared 2,700% in 2020. Of course, it's impossible to predict with 100% certainty which companies will succeed in the vaccine race — and whether their share prices will skyrocket. Gritstone Bio (NASDAQ: GRTS) is developing an mRNA vaccine candidate.
DISH Network (DISH) stock opened 3% higher on Wednesday amid a report that the satellite tv company is in talks with competitor DirecTV.
U.S. consumer prices rose at their fastest rate in nearly four decades in December, with inflationary pressures rippling through the economy as supply chain bottlenecks persisted alongside elevated demand.
Tilray, Inc.'s(NASDAQ: TLRY)story of 2021 has been the one of boom and bust (once again), as the stock repeated the performance from 2018 – albeit on a much smaller scale. Although the stock gained on earnings results, digging deeper shows things are not what they seem.
In this article, we will share with you the list of the top 22 packaging companies in USA. You can skip our detailed analysis of the USA’s packaging industry, and go directly to the Top 5 Packaging Companies in USA. The packaging industry has seen massive growth following a shift in consumer behavior around the […]
The transformed steelmaker rose on the back of soaring steel prices amid a global shortage last year.
TD Ameritrade Chief Market Strategist JJ Kinahan joins Yahoo Finance Live’s Akiko Fujita and Zack Guzman to discuss what investors are focused on amid higher inflation and earnings season.
Shares of the movie theater have fallen 16% though just six trading days in 2022. It doesn't have to end badly for AMC.

source

Share:

Pulse Handshak

Pulse Handshak

Collaborative online survey tool for the market research industry. Remote assisted surveying just like face-to-face interviews. Here interviewers can talk to the respondent over the web-console without the need for any other communication channel and share the same Q're with responses and click actions.

Pulse FE

Pulse FE

Pulse Field Expert or Pulse FE is the main platform for both offline and online survey at softofficepro.com. It is robust and used by hundreds of clients over tens of years with millions of responses. Do it once Q're and deploy on both offline devices (android) and online forms makes it a great cost effective platform for any kind of responses

Pulse Ultimate

Pulse Ultimate

Pulse Ultimate is targeted for tracking studies and retail audits. An offline survey system offering extreme field control including processes like data quality check, back-check, rework, comparison with previous wave data etc. helps to get the best results on a day-to-day basis

More Posts